Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03956082 · ClinicalTrials.gov registry record · NA

Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis

A NA study, sponsored by Mercy Research.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT03956082 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03956082, a NA study, has completed, sponsored by Mercy Research.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This is a prospective single arm study. The study will enroll 20 patients. Comparisons to prior clinical trials and published literature will be made to assess the relative significance of the study results.The study will enroll patients indicated for laparoscopic surgery to treat endometriosis. Patients must meet all inclusion/exclusion criteria. There are five main study objectives: 1. Demonstrate the feasibility of undertaking low impact laparoscopic surgery for endometriosis when using the Ultravision™ System. 2. Assess the impact of Ultravision on visual field clarity. 3. Determine the ability to complete the procedure while maintaining an abdominal pressure of \< 10mmHg. 4. Quantify the consumption of CO2. 5. Collect data on additional clinical outcomes associated with the use of Ultravision and low impact surgery (i.e. end tidal CO2 levels (EtCO2), adverse events, cosmesis outcome, postoperative pain levels and pain medications).

Interventions

  • DEVICE Ultravision™ Visual Field Clearing System
  • DEVICE Ultravision Ionwand™

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-08-07
Est. Completion 2021-04-14
Phase NA

Sponsor

Mercy Research

14 total trials

What the Registry Record Tells You About NCT03956082

The ClinicalTrials.gov registry entry for NCT03956082 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Research, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ultravision™ Visual Field Clearing System is the first listed.

NCT03956082 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03956082 about?

NCT03956082 is a clinical study titled "Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis". This is a prospective single arm study. The study will enroll 20 patients. Comparisons to prior clinical trials and published literature will be made to assess the relative significance of the study results.The study will enroll patients indicated for laparoscopic surgery to treat endometriosis. Pat...

What is the current status of trial NCT03956082?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-08-07. Estimated completion is 2021-04-14.

What interventions are being tested in trial NCT03956082?

The interventions under investigation include: Ultravision™ Visual Field Clearing System (DEVICE), Ultravision Ionwand™ (DEVICE).

Who is sponsoring clinical trial NCT03956082?

This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.